Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
03/2011
03/09/2011EP2292234A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof
03/09/2011EP2292233A2 Pharmaceutical uses of N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
03/09/2011EP2291349A2 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
03/09/2011EP1578733B1 Process for the preparation of rosuvastatin
03/09/2011EP1539711B1 Process for preparing the calcium salt of rosuvastatin
03/08/2011US7902360 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility
03/08/2011US7902359 Decahydronaphthalene compounds
03/08/2011US7902204 2-(4-Benzoyl-piperazin-1-yl)-3-(4-chloro-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3-oxo-propionitrile; HIV and AIDS
03/08/2011US7902187 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
03/08/2011CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels
03/03/2011WO2011025965A1 Raf inhibitor compounds and methods of use thereof
03/03/2011WO2011024468A1 Novel sulfonamide derivative and pharmaceutical product containing same
03/03/2011WO2011024429A1 Process for preparation of pyrimidinylacetonitrile derivatives and intermediates for synthesis thereof
03/03/2011WO2011024056A2 An improved process for the preparation of bosentan
03/03/2011WO2011023864A1 Pseudodipeptides as mmp inhibitors
03/03/2011WO2011023791A2 Method for producing organoaluminium compounds and use thereof
03/03/2011WO2008078200A3 Benzenesulfonamide derivatives as hiv protease inhibitors
03/03/2011US20110053932 Protein Kinase Inhibitors and Methods for Using Thereof
03/03/2011US20110053918 Gamma secretase modulators
03/03/2011US20110053901 Acetyl mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase
03/03/2011US20110053896 Osmolytes for the treatment of allergic or viral respiratory diseases
03/03/2011US20110053891 5-fluoropyrimidinone derivatives
03/03/2011US20110052701 Particulates of a crth2 antagonist
03/03/2011US20110052552 Compositions to effect neuronal growth
03/03/2011DE102008030091B4 Uracilderivate und deren Verwendung Uracil derivatives, and their use
03/03/2011CA2772575A1 Raf inhibitor compounds and methods of use thereof
03/03/2011CA2772071A1 Raf inhibitor compounds and methods of use thereof
03/02/2011EP2289881A1 Method for stereoselective synthesis of bicyclical heterocycles
03/02/2011EP2289871A1 7-substituted tetracycline compounds
03/02/2011EP2181098B1 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides
03/02/2011EP2081914B1 Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2h)-pyrimidinyl]-4-fluoro-n-[[methyl-(1-methyl-ethyl)amino]sulphonyl]benzamide
03/02/2011EP1585737B1 Uracils having a herbicidal activity
03/02/2011EP1578715B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
03/02/2011CN101983191A Oxim derivatives as hsp90 inhibitors
03/02/2011CN101104604B Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis
03/02/2011CN101035760B Compounds which potentiate glutamate receptor and uses thereof in medicine
03/01/2011US7897763 Process for the preparation of substituted phenylalanines
03/01/2011US7897607 Cyclic compounds
02/2011
02/24/2011WO2011022473A1 Biaryl compounds and methods of use thereof
02/24/2011WO2011022393A2 Phosphatidylcholine transfer protein inhibitors
02/24/2011WO2011022348A1 Ethylene diamine modulators of fatty acid amide hydrolase
02/24/2011WO2011021689A1 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
02/24/2011WO2011021212A1 Methods of treating drug resistant and other tumors with 6,7-dialkoxy quinazoline derivatives
02/24/2011WO2011021058A1 Process for the manufacture of rosuvastatin calcium using crystalline rosuvastatin ethyl ester
02/24/2011WO2011001113A3 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
02/24/2011WO2010150279A3 Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor
02/24/2011US20110046375 ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof
02/24/2011US20110046374 Pyrido[3,2-h]quinazolines and/or 5,6-dihydro Derivatives Thereof, a Method for the Production Thereof and Doped Organic Semiconductor Material Containing These
02/24/2011US20110046168 Methods of treating diseases using quinazoline derivatives and pharmaceutical compositions containing them
02/24/2011US20110046139 Benzocycloheptane and benzoxepine derivatives
02/24/2011US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
02/24/2011CA2770454A1 Biaryl compounds and methods of use thereof
02/23/2011EP2287156A1 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
02/23/2011EP2035401B1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
02/23/2011EP1737451B1 Monocyclic heterocycles as kinase inhibitors
02/23/2011EP1682520B1 Amide derivatives
02/23/2011CN1419537B Insecticidal anthranilamides
02/23/2011CN101981014A Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
02/23/2011CN101981003A Amide compounds, compositions and uses thereof
02/23/2011CN101979394A A method to inhibit ethylene responses in plants
02/23/2011CN101035770B Novel 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase ( BACE )
02/22/2011US7893261 bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity
02/22/2011US7893260 Substituted quinazolin-4-one compounds for antagonizing TRPV3 function
02/22/2011US7893075 Compounds modulating c-fms and/or c-kit activity and uses therefor
02/22/2011US7893074 inhibition of focal adhesion kinase or/and IGF-1 Receptor; for example: 2-[2-(2,5-Dimethoxy-phenylamino)-5-nitro-pyrimidin-4-ylamino]-N-methyl-benzenesulfonamide
02/22/2011US7893073 Heterocyclic derivatives
02/22/2011US7893072 Trp-p8 active compounds and therapeutic treatment methods
02/22/2011US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic
02/22/2011US7893063 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
02/22/2011CA2558501C 4-anilinoquinazolines derivatives with adenosine-kinase inhibitory properties
02/22/2011CA2476296C Amino-derivatives as inhibitors of histone deacetylase
02/22/2011CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
02/22/2011CA2328438C Heterocyclically substituted amides, their production and their use
02/17/2011WO2011018518A1 Regioselective preparation of 2 -amino-5-trifluoromethylpyrimidine derivatives
02/17/2011WO2011018517A1 Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
02/17/2011WO2010138828A3 Potassium channel modulators
02/17/2011US20110039865 Phenyl(oxy/thio)alkanol Derivatives
02/17/2011US20110039852 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
02/17/2011US20110039851 Ccr10 antagonists
02/17/2011US20110039847 Amide derivatives as sirtuin modulators
02/17/2011US20110039845 2-aminoquinazoline derivative
02/17/2011US20110039802 Npy y5 antagonist
02/17/2011US20110037024 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device
02/17/2011CA2767965A1 Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
02/16/2011EP2284160A1 Pyrimidine derivative having cell-protecting activity and use thereof
02/16/2011EP2284159A1 5-hydroxypyrimidine-4-carboxamide compound
02/16/2011EP2284152A2 Substituted tetracycline compounds
02/16/2011EP2283898A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/16/2011EP2283151A2 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof
02/16/2011EP2283011A1 2-phenyl-4-cyclopropyl-pyrimidine derivatives
02/16/2011EP2282740A1 Antifolate compositions
02/16/2011EP1771422B1 Quinazolinone derivatives as parp inhibitors
02/16/2011EP1664035B1 2,4 di(hetero)-arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
02/16/2011EP1309568B1 [(quinazolin-4-yl)piperazin-4-yl]thiocarboxamide compounds as inhibitors of the phosphorylation of a PDGF receptor
02/16/2011CN1989113B Quinazoline derivatives
02/16/2011CN101977900A 5-fluoro pyrimidine derivatives
02/16/2011CN101973944A New preparation method for crystal form Gefitinib Form 1
02/16/2011CN101973943A Preparation method of (E)-2-[2-(6-pyrimidine-4-yloxy) phenyl]-3-methoxyacrylate
02/16/2011CN101550108B Preparation method of environmental-friendly high-purity 2,4,6-trichloropyrimidine
02/16/2011CN101429165B Synthesis of quinazoline ketone compounds
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 427